STOCK TITAN

[144] Twist Bioscience Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Twist Bioscience Corp (TWST) filed a Form 144 reporting a proposed sale of 23,747 common shares with an aggregate market value of $764,344.69, representing part of shares acquired by restricted stock vesting on 10/01/2025. The filing lists the intended approximate sale date as 10/06/2025 on NASDAQ. It also discloses recent insider sales by Patrick Finn totaling 7,467 shares across 07/23/2025, 08/04/2025, 08/21/2025, and 10/02/2025 with combined gross proceeds visible in the table. The filer contact and CIK fields appear incomplete in the form, and no earnings or corporate operational details are included.

Twist Bioscience Corp (TWST) ha presentato un modulo 144 che segnala una prevista vendita di 23.747 azioni ordinarie per un valore di mercato cumulato di $764.344,69, rappresentante una parte delle azioni acquisite mediante vesting di azioni soggette a restrizioni il 01/10/2025. La submission indica la data di vendita prevista approssimativa come 06/10/2025 su NASDAQ. Riporta inoltre recenti vendite interne da Patrick Finn per un totale di 7.467 azioni tra il 23/07/2025, 04/08/2025, 21/08/2025 e il 02/10/2025 con i proventi lordi combinati visibili nella tabella. I contatti del fissatore e i campi CIK appaiono incompleti nel modulo, e non sono inclusi né dati sugli utili né dettagli operativi aziendali.

Twist Bioscience Corp (TWST) presentó un Formulario 144 reportando la venta propuesta de 23.747 acciones comunes por un valor de mercado agregado de $764.344,69, que representa parte de las acciones adquiridas por vesting de acciones restringidas el 01/10/2025. El archivo indica la fecha de venta aproximada prevista como 06/10/2025 en NASDAQ. También revela ventas internas recientes de Patrick Finn por un total de 7.467 acciones a través de 23/07/2025, 04/08/2025, 21/08/2025 y 02/10/2025 con los ingresos brutos combinados visibles en la tabla. Los campos de contacto del presentante y el CIK parecen incompletos en el formulario, y no se incluyen ganancias ni detalles operativos de la empresa.

Twist Bioscience Corp (TWST)23,747개의 보통주를 약정 매도하려는 Form 144를 제출했으며, 총 시장가치는 $764,344.69제한된 주식 가속 vesting으로 취득한 일부 주식을 나타냅니다 2025/10/01. 제출서는 매도 예정일을 대략 2025/10/06로 NASDAQ에서 명시합니다. 또한 Patrick Finn의 최근 내부 매각이 7,467주로 2025/07/23, 2025/08/04, 2025/08/21, 2025/10/02에 걸쳐 이루어졌고, 표에서 합산 총수익이 보이고 있습니다. 제출인 연락처 및 CIK 필드는 양식에서 불완전해 보이며, 수익이나 회사 운영에 관한 세부 정보는 포함되어 있지 않습니다.

Twist Bioscience Corp (TWST) a déposé un Formulaire 144 signalant une vente proposée de 23 747 actions ordinaires pour une valeur marchande totale de $764 344,69, représentant une partie des actions acquises par vesting d’actions restreintes le 01/10/2025. Le dossier indique la date de vente approximative prévue comme 06/10/2025 sur NASDAQ. Il divulge également des ventes internes récentes par Patrick Finn totalisant 7 467 actions à travers les dates 23/07/2025, 04/08/2025, 21/08/2025 et 02/10/2025 avec les recettes brutes combinées visibles dans le tableau. Le contact du déposant et les champs CIK semblent incomplets dans le formulaire, et aucun bénéfice ni détail opérationnel de l’entreprise n’est inclus.

Twist Bioscience Corp (TWST) hat ein Formular 144 eingereicht, das einen vorgeschlagenen Verkauf von 23.747 Stammaktien mit einem Gesamter Marktwert von $764.344,69 meldet, der einen Teil der Aktien darstellt, die durch bedingtes Aktienvesting am 01.10.2025 erworben wurden. Die Einreichung gibt das voraussichtliche ungefähre Verkaufsdatum als 06.10.2025 an und erfolgt an der NASDAQ. Sie offenbart außerdem kürzliche Insider-Verkäufe von Patrick Finn in Höhe von insgesamt 7.467 Aktien über die Daten 23.07.2025, 04.08.2025, 21.08.2025 und 02.10.2025, mit den im Diagramm sichtbaren Bruttoerlösen. Die Kontaktdaten des Meldenden und die CIK-Felder scheinen im Formular unvollständig zu sein, und es werden weder Gewinne noch betriebliche Details des Unternehmens aufgeführt.

Twist Bioscience Corp (TWST) قدمت نموذج 144 للإبلاغ عن بيع مقترح لـ 23,747 سهماً عادياً بقيمة سوقية إجمالية قدرها $764,344.69، وهو يمثل جزءاً من الأسهم المكتسبة عبر vesting الأسهم المقيدة في 01/10/2025. تفيد الوثيقة بأن تاريخ البيع المقصود التقريبي هو 06/10/2025 في NASDAQ. كما تكشف عن مبيعات داخلية حديثة من Patrick Finn بإجمالي 7,467 سهماً عبر التواريخ 23/07/2025، 04/08/2025، 21/08/2025 و 02/10/2025 مع الإيرادات الإجمالية الإجمالية الظاهرة في الجدول. تبدو جهة اتصال المقدم وحقول CIK غير كاملة في النموذج، ولا توجد أي أرباح أو تفاصيل تشغيلية للشركة مكونة.

Twist Bioscience Corp (TWST) 已提交 Form 144,报告拟议出售 23,747 股普通股,综合市场价值为 $764,344.69,代表通过 受限股票归属 获得的部分股票,日期为 2025/10/01。申报文件将预期大致出售日期列为 2025/10/06,在 NASDAQ 上进行。还披露了 Patrick Finn 的最近内部出售,总计 7,467 股,涉及 2025/07/232025/08/042025/08/212025/10/02,毛收入总额在表格中可见。申报者的联系信息和 CIK 字段在表格中似乎不完整,且未包含任何收益或公司运营细节。

Positive
  • 23,747 shares acquired by restricted stock vesting, indicating alignment of compensation with equity
  • Full transaction details provided: broker, dates, share counts and gross value ($764,344.69)
Negative
  • None.

Insights

TL;DR: An executive received restricted stock that is now listed for sale, adding modest supply to the market.

The filing shows 23,747 shares acquired by restricted stock vesting on 10/01/2025 and proposed for sale on 10/06/2025 through Fidelity Brokerage Services. The aggregate value reported is $764,344.69, implying a single-event liquidity realization for the insider.

Risks and dependencies include the timing of execution and market liquidity; the amount equals about 0.039 of the reported outstanding shares (23,747 of 60,360,925), a small fraction unlikely to move market price by itself. Monitor subsequent Form 4 or 144 amendments within days for execution details.

TL;DR: The notice documents compliance with Rule 144 for a vesting-related sale and includes standard seller certifications.

The filer certifies absence of undisclosed material adverse information and lists the sale as compensation-related. The form shows broker information and prior open-market sales by an individual named Patrick Finn during 07/23/202510/02/2025, with gross proceeds reported per trade.

From a compliance standpoint, watch for a matching Form 4 that records actual sale execution and for any trading-plan disclosure indicating Rule 10b5-1 protection; if absent, advisors often expect prompt Form 4 filing within required timeframes.

Twist Bioscience Corp (TWST) ha presentato un modulo 144 che segnala una prevista vendita di 23.747 azioni ordinarie per un valore di mercato cumulato di $764.344,69, rappresentante una parte delle azioni acquisite mediante vesting di azioni soggette a restrizioni il 01/10/2025. La submission indica la data di vendita prevista approssimativa come 06/10/2025 su NASDAQ. Riporta inoltre recenti vendite interne da Patrick Finn per un totale di 7.467 azioni tra il 23/07/2025, 04/08/2025, 21/08/2025 e il 02/10/2025 con i proventi lordi combinati visibili nella tabella. I contatti del fissatore e i campi CIK appaiono incompleti nel modulo, e non sono inclusi né dati sugli utili né dettagli operativi aziendali.

Twist Bioscience Corp (TWST) presentó un Formulario 144 reportando la venta propuesta de 23.747 acciones comunes por un valor de mercado agregado de $764.344,69, que representa parte de las acciones adquiridas por vesting de acciones restringidas el 01/10/2025. El archivo indica la fecha de venta aproximada prevista como 06/10/2025 en NASDAQ. También revela ventas internas recientes de Patrick Finn por un total de 7.467 acciones a través de 23/07/2025, 04/08/2025, 21/08/2025 y 02/10/2025 con los ingresos brutos combinados visibles en la tabla. Los campos de contacto del presentante y el CIK parecen incompletos en el formulario, y no se incluyen ganancias ni detalles operativos de la empresa.

Twist Bioscience Corp (TWST)23,747개의 보통주를 약정 매도하려는 Form 144를 제출했으며, 총 시장가치는 $764,344.69제한된 주식 가속 vesting으로 취득한 일부 주식을 나타냅니다 2025/10/01. 제출서는 매도 예정일을 대략 2025/10/06로 NASDAQ에서 명시합니다. 또한 Patrick Finn의 최근 내부 매각이 7,467주로 2025/07/23, 2025/08/04, 2025/08/21, 2025/10/02에 걸쳐 이루어졌고, 표에서 합산 총수익이 보이고 있습니다. 제출인 연락처 및 CIK 필드는 양식에서 불완전해 보이며, 수익이나 회사 운영에 관한 세부 정보는 포함되어 있지 않습니다.

Twist Bioscience Corp (TWST) a déposé un Formulaire 144 signalant une vente proposée de 23 747 actions ordinaires pour une valeur marchande totale de $764 344,69, représentant une partie des actions acquises par vesting d’actions restreintes le 01/10/2025. Le dossier indique la date de vente approximative prévue comme 06/10/2025 sur NASDAQ. Il divulge également des ventes internes récentes par Patrick Finn totalisant 7 467 actions à travers les dates 23/07/2025, 04/08/2025, 21/08/2025 et 02/10/2025 avec les recettes brutes combinées visibles dans le tableau. Le contact du déposant et les champs CIK semblent incomplets dans le formulaire, et aucun bénéfice ni détail opérationnel de l’entreprise n’est inclus.

Twist Bioscience Corp (TWST) hat ein Formular 144 eingereicht, das einen vorgeschlagenen Verkauf von 23.747 Stammaktien mit einem Gesamter Marktwert von $764.344,69 meldet, der einen Teil der Aktien darstellt, die durch bedingtes Aktienvesting am 01.10.2025 erworben wurden. Die Einreichung gibt das voraussichtliche ungefähre Verkaufsdatum als 06.10.2025 an und erfolgt an der NASDAQ. Sie offenbart außerdem kürzliche Insider-Verkäufe von Patrick Finn in Höhe von insgesamt 7.467 Aktien über die Daten 23.07.2025, 04.08.2025, 21.08.2025 und 02.10.2025, mit den im Diagramm sichtbaren Bruttoerlösen. Die Kontaktdaten des Meldenden und die CIK-Felder scheinen im Formular unvollständig zu sein, und es werden weder Gewinne noch betriebliche Details des Unternehmens aufgeführt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Twist Bioscience's (TWST) Form 144 report?

It reports a proposed sale of 23,747 common shares valued at $764,344.69, with an approximate sale date of 10/06/2025 on NASDAQ.

How were the shares acquired for the TWST sale?

The shares were acquired by restricted stock vesting on 10/01/2025 and payment is listed as compensation.

Who executed recent insider sales listed in the filing?

The filing shows recent sales by Patrick Finn on 07/23/2025, 08/04/2025, 08/21/2025, and 10/02/2025 totaling 7,467 shares with gross proceeds shown per trade.

Does the Form 144 include the filer CIK or contact details?

The form's CIK and submission contact fields appear incomplete or blank; full filer identity details are not provided in the content.

Will this sale materially dilute TWST shares outstanding?

The proposed sale of 23,747 shares is approximately 0.039 of the reported 60,360,925 outstanding shares, a small percentage that is not likely to cause material dilution by itself.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.92B
59.19M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO